Mahmoud Houmsse

Dr. Mahmoud Houmsse


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
PDF file
RSReynaldo Sanchez
Reynaldo Sanchez
ANAnish Nadkarni
Anish Nadkarni
BBBenjamin Buck
Benjamin Buck
GDGeorges Daoud
Georges Daoud
TKTanner Koppert
Tanner Koppert
MAMuhammad R. Afzal
Muhammad R. Afzal
Introduction: Frequent right AQ4ventricular pacing (≥40%) with a transvenous pacemaker (TVP) is associated with the risk of pacing‐induced cardiomyopathy (PICM). Leadless pacemakers (LPs) have distinct physical and mechanical differences from TVP. The risk of PICM with LP is not known. To identify incidence, predictors, and long‐term outcomes of PICM in LP and TVP patients.Methods: The study comprised all pacemaker‐dependent patients with LP or TVP who had left ventricular ejection fraction (LVEF) of ≥50 from 2014 to 2019. The incidence of PICM (≥10% LVEF drop) was assessed with an echocardiogram. Predictors for PICM were identified using multivariate analysis. Long‐term outcomes after cardiac resynchronization (CRT) were assessed in both groups.Results: A total of 131 patients with TVP and 67 with LP comprised the study. All patients in the TVP group and the majority in the LP group underwent atrioventricular node ablation. The mean follow‐up duration in TVP and LP groups was 592 ± 549 and 817 ± 600 days, respectively. A total of 18 (13.7%) patients in TVP and 2 (3%) in LP developed PICM after a median duration of 254 (interquartile range: 470) days. The incidence of PICM was significantly higher with TVP compared with LP (p = .02). TVP as pacing modality was a positive (odds ratio [OR]: 1.07) while age was negative (OR: 0.94) predictor for PICM on multivariable analysis. Both patients in LP and all except two in the TVP group responded to CRT.Conclusion: Incidence of PICM is significantly lower with LP compared with TVP in pacemaker‐dependent patients. Age and TVP as pacing modality were predictors for PICM.

1 January 2016 in Avicenna Journal of Medicine
Verified
Journal Article
Open access
PDF file
AAAnish Amin
Anish Amin
AHAseel Houmsse
Aseel Houmsse
AIAbiodun Ishola
Abiodun Ishola
JTJaret Tyler
Jaret Tyler
MHMahmoud Houmsse
Mahmoud Houmsse
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice. Aging populations coupled with improved outcomes for many chronic medical conditions has led to increases in AF diagnoses. AF is also known to be associated with an increased risk of adverse events such as transient ischemic attack, ischemic stroke, systemic embolism, and death. This association is enhanced in select populations with preexisting comorbid conditions such as chronic heart failure. The aim of this review is to highlight the advances in the field of cardiology in the management of AF in both acute and long-term settings. We will also review the evolution of anticoagulation management over the past few years and landmark trials in the development of novel oral anticoagulants (NOACs), reversal agents for new NOACs, nonpharmacological options to anticoagulation therapy, and the role of implantable loop recorder in AF management.

1 May 2011 in Current Opinion in Cardiology
Verified
Journal Article
Closed access
MHMahmoud Houmsse
Mahmoud Houmsse
JTJaret Tyler
Jaret Tyler
SKSteven Kalbfleisch
Steven Kalbfleisch
Supraventricular tachycardia (SVT) causing heart failure is an important cause of tachycardia-induced cardiomyopathy. Advances in anti-arrhythmic drugs to achieve either rate or rhythm control, curative ablative therapy directed at the underlying tachycardia mechanism to restore sinus rhythm, and atrioventricular junction ablation with permanent pacemaker placement for better rate control have improved the outcome of SVT management and subsequently improved the heart failure symptomatology and in some cases reversed remodeling of the cardiac dysfunction. The aim of this review is to provide the reader with clinical presentation as well as the common SVTs causing heart failure, pathophysiology of SVT causing heart failure, evaluation and management of SVT causing heart failure, and prognosis of SVT causing heart failure.

9 January 2012 in Expert Review of Medical Devices
Verified
Journal Article
Closed access
MHMahmoud Houmsse
Mahmoud Houmsse
EDEmile G Daoud
Emile G Daoud
Catheter ablation by radiofrequency (RF) energy has successfully eliminated cardiac tachyarrhythmias. RF ablation lesions are created by thermal energy. Electrode catheters with 4-mm-tips have been adequate to ablate arrhythmias located near the endocardium; however, the 4-mm-tip electrode does not readily ablate deeper tachyarrhythmia substrate. With 8- and 10-mm-tip RF electrodes, ablation lesions were larger; yet, these catheters are associated with increased risk for coagulum, char and thrombus formation, as well as myocardial steam rupture. Cooled-tip catheter technology was designed to cool the electrode tip, prevent excessive temperatures at the electrode tip-tissue interface, and thus allow continued delivery of RF current into the surrounding tissue. This ablation system creates larger and deeper ablation lesions and minimizes steam pops and thrombus formation. The purpose of this article is to review cooled-tip RF ablation biophysics and outcomes of clinical studies as well as to discuss future technological improvements.

18 November 2019 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
MAMuhammad R. Afzal
Muhammad R. Afzal
TOToshimasa Okabe
Toshimasa Okabe
TKTanner Koppert
Tanner Koppert
JTJaret Tyler
Jaret Tyler
MHMahmoud Houmsse
Mahmoud Houmsse
MEMichael Essandoh
Michael Essandoh

30 April 2011 in Heart Failure Clinics
Verified
Journal Article
Closed access
MHMahmoud Houmsse
Mahmoud Houmsse
VFVeronica Franco
Veronica Franco
WAWilliam T. Abraham
William T. Abraham